Pharmaceutical intermediates
Peramivir Intermediates
3 pharmaceutical intermediates for Peramivir. Indication: Influenza, Human.
About Peramivir
- Originator
- Biocryst Pharmaceuticals, Inc
- Indication
- Influenza, Human
- Approved Date
- 12/19/2014
- DS/DP
- 02/12/2027
Available intermediates
3 intermediates currently listed for Peramivir. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| (1S,4R)-methyl 4-(Boc-amino)cyclopent-2-enecarboxylate | 168683-02-1 | / | / |
| (3aR,4R,6S,6aS)-4-(tert-butoxycarbonylaMino)-3- (pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylic acid | 316173-28-1 | / | / |
| (3aR,4R,6S,6aS)-4-[[(1,1-DiMethylethoxy)carbonyl]aMino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]isoxazole-6-carboxylic Acid Methyl Ester | 229613-93-8 | / | / |
Building toward Peramivir?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →